Inventor · disambiguated record
Jonathan F. Smith
Also filed as: SMITH JONATHAN · SMITH JONATHAN F · SMITH JONATHAN FOWLER
40 granted patents·15 pending applications·1,668 citations·filing 1989–2025
98Inventor score
Top patents by PatentIndex Score
55 records- 0196US9441247B2TC-83-derived alphavirus vectors, particles and methodsALPHAVAX INC·Filed 2015·Granted Sep 13, 2016·36 cites·14 claims
- 0296US6531135B1Alphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 2000·Granted Mar 11, 2003·56 cites·91 claims
- 0396US6521235B2Alphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 2001·Granted Feb 18, 2003·55 cites·78 claims
- 0496US6156558AAlphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 1998·Granted Dec 5, 2000·125 cites·76 claims
- 0596US5792462AAlphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 1995·Granted Aug 11, 1998·206 cites·27 claims
- 0696US5643576AMethod of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogenUNIV NORTH CAROLINA·Filed 1995·Granted Jul 1, 1997·238 cites·12 claims
- 0795US7425337B2Alphavirus replicon vector systemsALPHAVAX INC·Filed 2006·Granted Sep 16, 2008·45 cites·34 claims
- 0895US7045335B2Alphavirus replicon vector systemsALPHAVAX INC·Filed 2002·Granted May 16, 2006·69 cites·25 claims
- 0993US7442381B2Alphavirus replicons and helper constructsALPHAVAX INC·Filed 2004·Granted Oct 28, 2008·72 cites·94 claims
- 1093US5505947AAttenuating mutations in Venezuelan Equine Encephalitis virusUNIV NORTH CAROLINA·Filed 1994·Granted Apr 9, 1996·120 cites·11 claims
- 1192US8460913B2Promoterless cassettes for expression of alpha virus structural proteinsKAMRUD KURT I·Filed 2008·Granted Jun 11, 2013·36 cites·6 claims
- 1291US7850977B2Promoterless cassettes for expression of alphavirus structural proteinsALPHAVAX INC·Filed 2008·Granted Dec 14, 2010·13 cites·21 claims
- 1391US7078218B2Alphavirus particles and methods for preparationALPHAVAX INC·Filed 2003·Granted Jul 18, 2006·66 cites·28 claims
- 1491US5185440AcDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereofUNIV NORTH CAROLINA STATE·Filed 1989·Granted Feb 9, 1993·148 cites·5 claims
- 1590US8709441B2TC-83-derived alphavirus vectors, particles and methodsRAYNER JON O·Filed 2010·Granted Apr 29, 2014·23 cites·7 claims
- 1690US6541010B1Alphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 1997·Granted Apr 1, 2003·70 cites·37 claims
- 1788US8617533B2Multi-antigenic alphavirus replicon particles and methodsSMITH JONATHAN F·Filed 2008·Granted Dec 31, 2013·10 cites·19 claims
- 1886US6984504B2Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus repliconsUS ARMY·Filed 2003·Granted Jan 10, 2006·10 cites·4 claims
- 1985US9416370B2Alphavirus replicon particles matched to protein antigens as immunological adjuvantsSMITH JONATHAN F·Filed 2010·Granted Aug 16, 2016·10 cites·10 claims
- 2084US7455994B2Methods for producing Marburg virus proteinsUS ARMY·Filed 2006·Granted Nov 25, 2008·3 cites·5 claims
- 2184US7235235B2Alphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 2003·Granted Jun 26, 2007·13 cites·22 claims
- 2284US6495143B2Botulinum neurotoxin vaccineUS ARMY·Filed 1999·Granted Dec 17, 2002·67 cites·28 claims
- 2383US8680258B2Use of microRNAs to control virus helper nucleic acidsCOFFIELD VERNON MCNEIL·Filed 2009·Granted Mar 25, 2014·9 cites·31 claims
- 2483US6770479B1Anthrax vaccineUS ARMY·Filed 1999·Granted Aug 3, 2004·38 cites·19 claims
- 2582US10434187B2Use of microRNAs to control virus helper nucleic acidsALPHAVAX INC·Filed 2017·Granted Oct 8, 2019·3 cites·20 claims
- 2681US10111943B2Alphavirus replicon particles matched to protein antigens as immunological adjuvantsALPHAVAX INC·Filed 2016·Granted Oct 30, 2018·3 cites·3 claims
- 2780US9079943B2TC-83-derived alphavirus vectors, particles and methodsALPHAVAX INC·Filed 2014·Granted Jul 14, 2015·3 cites·9 claims
- 2879US10004797B2Method of rapidly producing improved vaccines for animalsHARRISVACCINES INC·Filed 2012·Granted Jun 26, 2018·3 cites·9 claims
- 2979US6632640B1Vaccine against Staphylococcus intoxicationUS ARMY·Filed 1999·Granted Oct 14, 2003·28 cites·9 claims
- 3078US9597414B2Use of microRNAs to control virus helper nucleic acidsALPHAVAX INC·Filed 2014·Granted Mar 21, 2017·3 cites·30 claims
- 3178US7090852B2Venezuelan equine encephalitis virus replicon encoding marburg virus proteinsUS ARMY·Filed 2002·Granted Aug 15, 2006·4 cites·6 claims
- 3276US8263092B1Alphavirus replicon particles as immunological adjuvantsSMITH JONATHAN F·Filed 2007·Granted Sep 11, 2012·5 cites·17 claims
- 3375US2024401081A1Cytokine immunotherapyVLP THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3474US7374931B2Vaccine against staphylococcus intoxicationUS ARMY·Filed 2003·Granted May 20, 2008·2 cites·6 claims
- 3574US6261570B1Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variantsUS ARMY·Filed 1997·Granted Jul 17, 2001·42 cites·22 claims
- 3670US7638333B2Anthrax vaccineUS ARMY·Filed 2003·Granted Dec 29, 2009·1 cites·10 claims
- 3768US12134777B2Alphavirus replicon vector and immunotherapy by administering sameVLP THERAPEUTICS INC·Filed 2021·Granted Nov 5, 2024·0 cites·17 claims
- 3867US6296854B1Live attenuated Venezuelan Equire encephalitis vaccineUS ARMY·Filed 1999·Granted Oct 2, 2001·24 cites·4 claims
- 3967US2025228931A1Alphavirus replicon encoding chimeric sars-cov-2 receptor binding domainsVLP THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4066US12280102B2Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domainsVLP THERAPEUTICS INC·Filed 2021·Granted Apr 22, 2025·0 cites·16 claims
- 4166US2024335528A1Efficient vaccineVLP THERAPEUTICS JAPAN INC·Filed 2024·Application pending·0 cites
- 4265US2004121466A1Alphavirus RNA replicon systemsUNIV NORTH CAROLINA·Filed 2003·Application pending·0 cites
- 4359US10570416B2TC-83-derived alphavirus vectors, particles and methodsALPHAVAX INC·Filed 2016·Granted Feb 25, 2020·0 cites·14 claims
- 4458US6517842B1Marburg virus vaccinesUS ARMY·Filed 1999·Granted Feb 11, 2003·9 cites·12 claims
- 4558US2023201333A1Efficient vaccineVLP THERAPEUTICS JAPAN LLC·Filed 2022·Application pending·0 cites
- 4656US2005266550A1TC-83-derived alphavirus vectors, particles and methodsALPHAVAX INC·Filed 2005·Application pending·0 cites
- 4756US2009022760A1Alphavirus Replicon Particles Matched to Protein Antigens as Immunological AdjuvantsALPHAVAX·Filed 2007·Application pending·0 cites
- 4855US2013122025A1Method of rapidly producing improved vaccines for animalsHARRISVACCINES INC·Filed 2013·Application pending·0 cites
- 4950US2004208848A1Multi-antigenic alphavirus replicon particles and methodsFiled 2003·Application pending·0 cites
- 5050US2006099587A1Alphavirus vectors having attentuated virion structural proteinsJOHNSTON ROBERT E·Filed 2003·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jonathan F. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →